Thoma Bravo Fund X, L.P.'s Form 4 filing
Dynatrace, Inc. (DT) · filed Nov 17, 2023
- Accession no.
- 0000950170-23-064799
- Filed
- Nov 17, 2023, 4:05 PM ET
- Trade date
- Nov 15, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $500.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thoma Bravo Fund X, L.P.CIK 0001537211 | 10% Owner |
| Thoma Bravo Fund X-A, L.P.CIK 0001537212 | 10% Owner |
| Thoma Bravo Special Opportunities Fund I, L.P.CIK 0001579904 | 10% Owner |
| Thoma Bravo Fund XI, L.P.CIK 0001606286 | 10% Owner |
| Thoma Bravo Fund XI-A, L.P.CIK 0001606287 | 10% Owner |
| Thoma Bravo Executive Fund XI, L.P.CIK 0001606288 | 10% Owner |
| Thoma Bravo Partners XI, L.P.CIK 0001722232 | 10% Owner |
| Thoma Bravo Partners X, L.P.CIK 0001783009 | 10% Owner |
| Thoma Bravo Special Opportunities Fund I Aiv, L.P.CIK 0001783011 | 10% Owner |
| Thoma Bravo Ugp, LLCCIK 0001813487 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 15, 2023 | Common Stock | SSaleDisposed | −10,000,000 | $50.00 | −$500,000,000 | 31,857,273 | Indirect | |
| Nov 15, 2023 | Common Stock | JOtherDisposed | −2,576,137 | –F3 | – | 31,857,273 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
Represents a distribution of (i) 159,600 shares held directly by TB SOF AIV, 22,217 shares held directly by TB SOF, 309,847 shares held directly by TB Fund X and 53,882 shares held directly by TB Fund X-A, in each case to TB Partners X, and (ii) 25,609 shares held directly by TB Exec Fund, 1,450,201 shares held directly by TB Fund XI, and 554,781 shares held directly by TB Fund XI-A, in each case to TB Partners XI.
Referenced by the price of 1 transaction in Table I.